Journal article
Falsely Elevated Serum Digoxin Levels Secondary to Endogenous Digoxin‐like Immunoreactive Substances
Academic emergency medicine, v 2(4), pp 322-326
Apr 1995
PMID: 11727693
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
ABSTRACT
Endogenous digoxin‐like immunoreactive substances (DLIS) are produced by the human body and can be significantly elevated in specific clinical conditions. Commercially available digoxin assays do not have the specificity to fully distinguish DLIS from exogenous digoxin, though DLIS do not possess the same therapeutic properties as do the drug. The resultant artificial elevation of a reported digoxin level or a completely factitious level in a patient not taking the drug can have clinically significant consequences.
Metrics
Details
- Title
- Falsely Elevated Serum Digoxin Levels Secondary to Endogenous Digoxin‐like Immunoreactive Substances
- Creators
- Thomas J. Koobatian - The Medical College of Pennsylvania, Philadelphia Department of Emergency Medicine. Division of ToxicologyJames R. Roberts - Mercy Catholic Medical Center
- Publication Details
- Academic emergency medicine, v 2(4), pp 322-326
- Publisher
- Blackwell Publishing Ltd
- Number of pages
- 5
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Emergency Medicine
- Web of Science ID
- WOS:A1995RA30200017
- Scopus ID
- 2-s2.0-0029278979
- Other Identifier
- 991019184206904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Emergency Medicine